6543. Laetrile (Formula L).   (F.D.C. No. 45170.   S. Nos. 31-106/7 R.) 
QXTANITITY :    50 vials of Laetrile and 14 vials of Formula L at Dallas, Tex., in
possession of Taylor Clinic. 
SHIPPED:   Between 9-30-60 and 10-21-60, from Los Angeles, Calif., by Hale
Laboratories, Inc. 
LABEL   IN   PART:    (Vial)    "Laetrile   500   mg.   Sodium  1-mandelonitrile-beta-
glucuronoside.   Caution: * * * New Drug * * * Hale Laboratories, Inc. * * *
Los Angeles 64, California 1423" and "Formula L: Mix with 10 cc sterile water.
Give 5 cc each injection.   Note: Injections 3 times weekly."
RESULTS OF INVESTIGATION : The 14-vial lot was the "Laetrile^ product which 
had been relabeled by the dealer as "Formula L."
LIBELED :   12-28-60, N. Dist. Tex.
CHARGE: 505(a)-the article was a new drug which may not be introduced 
into or delivered for introduction into interstate commerce since it was sold 
for investigational purposes and was not being so used, and an application 
filed pursuant to 505 (h) was not effective with respect to such drug.
DISPOSITION : 2-7-61.   Default-delivered to the Food and Drug Administration.
DRUGS REQUIRING CERTIFICATE OR RELEASE, FOR WHICH NONE
HAD BEEN ISSUED
DRUG FOR HUMAN USE